OPTIMER PHARMACEUTICALS INC Earnings Per Share (Basic)
OPTIMER PHARMACEUTICALS INC reported Earnings Per Share (Basic) of $0.02 per share for the 3-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2013-03-18
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for the quarter ending 2012-12-31 was $0.02, a 93.10% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for the quarter ending 2012-09-30 was -$0.56.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for the quarter ending 2012-06-30 was -$0.01.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for the quarter ending 2012-03-31 was -$0.23, a 121.70% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for fiscal 2012 was -$0.78, a 558.82% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for fiscal 2011 was $0.17.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for fiscal 2010 was -$1.25.
- OPTIMER PHARMACEUTICALS INC earnings per share, basic for fiscal 2009 was -$1.30.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.02 10-K · filed 2013-03-18 | -$0.78 10-K · filed 2013-03-18 | ||
| 2012-09-30 | -$0.56 10-K · filed 2013-03-18 | |||
| 2012-06-30 | -$0.01 10-K · filed 2013-03-18 | -$0.24 10-Q · filed 2012-08-03 | $0.05 derived: net income ÷ weighted average shares · filed 2013-08-07 | -$0.52 derived: net income ÷ weighted average shares · filed 2013-08-07 |
| 2012-03-31 | -$0.23 10-K · filed 2013-03-18 | $0.05 derived: net income ÷ weighted average shares · filed 2013-05-10 | -$0.51 derived: net income ÷ weighted average shares · filed 2013-05-10 | -$1.03 derived: net income ÷ weighted average shares · filed 2013-05-10 |
| 2011-12-31 | $0.29 10-K · filed 2013-03-18 | -$0.28 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$0.80 derived: net income ÷ weighted average shares · filed 2013-03-18 | $0.17 10-K · filed 2013-03-18 |
| 2011-09-30 | -$0.57 10-K · filed 2013-03-18 | -$1.09 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$0.12 10-Q · filed 2011-11-03 | -$0.40 derived: net income ÷ weighted average shares · filed 2013-03-18 |
| 2011-06-30 | -$0.52 10-K · filed 2013-03-18 | $0.47 10-Q · filed 2012-08-03 | $0.21 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$0.07 derived: net income ÷ weighted average shares · filed 2013-03-18 |
| 2011-03-31 | $1.06 10-K · filed 2013-03-18 | $0.81 derived: net income ÷ weighted average shares · filed 2013-03-18 | $0.53 derived: net income ÷ weighted average shares · filed 2013-03-18 | |
| 2010-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$0.61 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$1.25 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$0.30 10-Q · filed 2011-11-03 | -$0.95 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$0.26 10-Q · filed 2011-08-04 | -$0.64 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | -$1.30 10-K · filed 2012-03-08 |